FDA Inspection 1322276 — Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park)
The FDA completed an inspection of Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park) on May 8, 2026 in Jinan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 8, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinan (China)